LRMR icon

Larimar Therapeutics

81 hedge funds and large institutions have $43.4M invested in Larimar Therapeutics in 2016 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

0% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 23

4% less capital invested

Capital invested by funds: $45.4M → $43.4M (-$1.96M)

72% less call options, than puts

Call options by funds: $140K | Put options by funds: $495K

Holders
81
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$140K
Puts
$495K
Net Calls
Net Calls Change

Top Buyers

1 +$1.91M
2 +$1.59M
3 +$986K
4
Millennium Management
Millennium Management
New York
+$844K
5
PP
Paloma Partners
Connecticut
+$352K

Top Sellers

1 -$1.99M
2 -$1.59M
3 -$878K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$762K
5
Northern Trust
Northern Trust
Illinois
-$468K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$327K
27
$313K
28
$283K
29
$226K
30
$170K
31
$152K
32
$151K
33
$142K
34
$141K
35
$137K
36
$134K
37
$122K
38
$102K
39
$99K
40
$93K
41
$76K
42
$76K
43
$75K
44
$68K
45
$64K
46
$64K
47
$63K
48
$60K
49
$59K
50
$53K